< 生产厂家价格 >

2-甲基-2-丙烯酸-2-(2-甲氧基乙氧基)乙酯

2-甲基-2-丙烯酸-2-(2-甲氧基乙氧基)乙酯名称

[ CAS 号 ]:
45103-58-0

[ 中文名 ]:
2-甲基-2-丙烯酸-2-(2-甲氧基乙氧基)乙酯

[ 英文名 ]:
2-(2-methoxyethoxy)ethyl methacrylate

[中文别名 ]:

[英文别名 ]:

Diethylene Glycol MonoMethyl Ether Methacrylate
EINECS 256-190-2
2-(2-Methoxyethoxy)ethyl Methacrylate
Methacrylic Acid 2-(2-Methoxyethoxy)ethyl Ester
Methyl Carbitol Methacrylate
MFCD00059330

2-甲基-2-丙烯酸-2-(2-甲氧基乙氧基)乙酯物理化学性质

[ 密度 ]:
1.02 g/mL at 25ºC(lit.)

[ 沸点 ]:
98ºC3.5 mm Hg(lit.)

[ 分子式 ]:
C₉H₁₆O₄

[ 分子量 ]:
188.22100

[ 闪点 ]:
>230 °F

[ 精确质量 ]:
188.10500

[ PSA ]:
44.76000

[ LogP ]:
0.76870

[ 外观性状 ]:
液体;Colorless to Almost colorless clear liquid

[ 折射率 ]:
n20/D 1.44(lit.)

[ 储存条件 ]:
0-10°C;避免加热

2-甲基-2-丙烯酸-2-(2-甲氧基乙氧基)乙酯MSDS

2-甲基-2-丙烯酸-2-(2-甲氧基乙氧基)乙酯安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H315-H317-H319-H335

[ 警示性声明 ]:
P261-P280-P305 + P351 + P338

[ 个人防护装备 ]:
Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ 危害码 (欧洲) ]:
Xi

[ 风险声明 (欧洲) ]:
36/37/38-43

[ 安全声明 (欧洲) ]:
26-36/37

[ 危险品运输编码 ]:
NONH for all modes of transport

[ 海关编码 ]:
2916140000

2-甲基-2-丙烯酸-2-(2-甲氧基乙氧基)乙酯合成路线

2-甲基-2-丙烯酸-2-(2-甲氧基乙氧基)乙酯上下游产品

2-甲基-2-丙烯酸-2-(2-甲氧基乙氧基)乙酯上游产品

2-甲基-2-丙烯酸-2-(2-甲氧基乙氧基)乙酯下游产品

2-甲基-2-丙烯酸-2-(2-甲氧基乙氧基)乙酯海关

[ 海关编码 ]: 2916140000

[ 中文概述 ]:
2916140000. 甲基丙烯酸酯. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:80.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 丙烯酸、丙烯酸盐或酯应报明包装

[ Summary ]:
2916140000. other esters of methacrylic acid. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:80.0%

2-甲基-2-丙烯酸-2-(2-甲氧基乙氧基)乙酯文献

Hydrophilicity/Hydrophobicity reversable and redox-sensitive nanogels for anticancer drug delivery.

Mol. Pharm. 12 , 1636-47, (2015)

Long circulation in the blood, efficient cellular internalization, and intracellular drug release in the tumor cells are major challenges in the development of ideal anticancer drug delivery systems. ...

Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers.

ACS Nano 9 , 11023-33, (2015)

A new ultrasound-responsive system based on mesoporous silica nanoparticles was developed for biomedical applications, grafting a copolymer on their surface that acts as gatekeeper of the pores. The n...

"Triple-punch" strategy for triple negative breast cancer therapy with minimized drug dosage and improved antitumor efficacy.

ACS Nano 9(2) , 1367-78, (2015)

Effective therapeutics against triple negative breast cancer (TNBC), which has no standard-of-care therapy, needs to be developed urgently. Here we demonstrated a strategy of integrating indocyanine g...

更多文献